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Abstract
A new family of "RuCp" (Cp=η(5)-C(5)H(5)) derivatives with bidentate N,O and N,N'-heteroaromatic
ligands revealed outstanding cytotoxic properties against several human cell lines namely, A2780,
A2780CisR, HT29, MCF7, MDAMB231, and PC3. IC(50) values were much lower than those found
for cisplatin. Crystal structure of compound 4 was determined by X-ray diffraction studies. Density
functional theory (DFT) calculations performed for compound 1 showed electronic flow from the
ruthenium center to the coordinated bidentate ligand, in agreement with the electrochemical studies
and the existence of a metal-to-ligand charge-transfer (MLCT) band evidenced by spectroscopic
data.
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